NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · IEX Real-Time Price · USD
20.30
-0.28 (-1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $1.83 billion. The enterprise value is $1.31 billion.

Market Cap 1.83B
Enterprise Value 1.31B

Important Dates

The last earnings date was Friday, March 31, 2023.

Earnings Date Mar 31, 2023
Ex-Dividend Date n/a

Share Statistics

NAMS has 89.99 million shares outstanding.

Shares Outstanding 89.99M
Owned by Insiders (%) 5.71%
Owned by Institutions (%) 84.92%
Float 29.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.13
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.17, with a Debt / Equity ratio of 0.00.

Current Ratio 8.17
Quick Ratio 8.17
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +69.17% in the last 52 weeks. The beta is 0.01, so NAMS's price volatility has been lower than the market average.

Beta (5Y) 0.01
52-Week Price Change +69.17%
50-Day Moving Average 20.04
200-Day Moving Average 16.13
Relative Strength Index (RSI) 56.86
Average Volume (20 Days) 162,283

Short Selling Information

Short Interest 259,564
Short Previous Month 246,222
Short % of Shares Out 0.49%
Short % of Float n/a
Short Ratio (days to cover) 1.70

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income n/a
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) -$2.70
Full Income Statement

Balance Sheet

The company has $517.18 million in cash and $46,221 in debt, giving a net cash position of $517.14 million or $5.75 per share.

Cash & Cash Equivalents 517.18M
Total Debt 46,221
Net Cash 517.14M
Net Cash Per Share $5.75
Equity (Book Value) 442.65M
Book Value Per Share 4.92
Working Capital 460.16M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.92%
Shareholder Yield -14.92%
Earnings Yield n/a
FCF Yield n/a

Analyst Forecast

The average price target for NAMS is $33.25, which is 63.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.25
Price Target Difference 63.79%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 35.90%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date Nov 23, 2022
Split Type n/a
Split Ratio 1:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a